8620

Organization name

ICB Pharma spółka z ograniczoną odpowiedzialnością

SRN

PL-MF-000007145

Manufacturer status

Active

11 warnings recorded — scroll inside the panel to see all entries.

• CW083

  EUDAMED did not publish a description for this code.
• CW275

  EUDAMED did not publish a description for this code.
• CW010

  EUDAMED did not publish a description for this code.
• CW007

  EUDAMED did not publish a description for this code.
• CW032

  EUDAMED did not publish a description for this code.
• CW135

  EUDAMED did not publish a description for this code.
• CW149

  EUDAMED did not publish a description for this code.
• CW318

  EUDAMED did not publish a description for this code.
• CW416

  EUDAMED did not publish a description for this code.
• CW413

  EUDAMED did not publish a description for this code.
• CW207

  EUDAMED did not publish a description for this code.

Primary placement in Poland; available across 1 country total.

Placed on the market in Poland; per-country availability dates not published.

Trade name

not provided

UDI-DI code

05904215273653

Basic UDI-DI

590421527NitolicPreventXH

Reference / catalog number

8620

Issuing entity

GS1

Risk category

Class I

Applicable legislation

MDR [Regulation (EU) 2017/745 on medical devices]

Status

On the market

Quantity

1

Additional product description

Wyrób medyczny przeznaczony do stosowania u ludzi do zapobiegania występowaniu lub nawrotowi wszawicy wywołanej przez wesz głowową (Pediculus humamis capitis).

Additional information URL

No additional information URL provided by the manufacturer.

Clinical sizes

• 150 MU03

European Medical Device Nomenclature — the EU product classification assigned to this device.

• V9099VARIOUS DEVICES NOT INCLUDED IN OTHER CLASSES - OTHER